Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Tumor suppressor and oncogene biomarkers predictive of anti-immune checkpoint inhibitor response

Tumor suppressor and oncogene biomarkers predictive of anti-immune checkpoint inhibitor response

US Patent 11624093 · Granted Apr 11, 2023

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Chimeric antigen receptors and uses thereof2025
Therapeutic targeting of KMT2D mutant lung squamous cell carcinoma through RTK-R2025
Cosmetic bag2025
Methods and compositions relating to lung cell differentiation2024
Use of alveolar or airway organoids for the treatment of lung diseases and disor2024
Compositions and methods for immunooncology2024
Combination vaccine devices and methods of killing cancer cells2024
Combination therapy for treatment of LKB1 deficient cancers2024
Methods for identification, assessment, prevention, and treatment of cancer usin2024
Compositions and methods of modulating anti-tumor immunity2024
NKG2D-IG fusion protein for cancer immunotherapy2023
Methods and compositions for reducing immunosuppression by tumor cells2023